11-09-2017 08:44 AM CET - Health & Medicine
Print

Hypercalcemia Treatment Market Would Reach at a +11.5% of CAGR Increasing Hip & Knee Replacement Procedures - Forecast to 2024

Press release from: Data Bridge Market Research
Hypercalcemia Treatment Market 2017: Global Industry Trends and Forecast to 2024
Hypercalcemia Treatment Market 2017: Global Industry Trends and Forecast to 2024


The “Global Hypercalcemia Treatment Market” accounted to USD 76.9 billion in 2016 growing at a CAGR of 11.5% during the forecast period of 2017 to 2024.

Global Hypercalcemia Treatment Market By Technology (Bisphosphonates (Clodronate, Etidronate, Ibandronate, Pamidronate and Zoledronic acid), Calcitonin, Glucocorticoids, Denosumab, Calcimimetics), By Distribution Channel (Direct Tenders, Retail), By End User (Hospitals, Clinics), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

This report consists of below pages:

• No of pages: 350
• No of Figures: 60
• No of Tables: 220

Get Free Sample Report Visit @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Report Definition:

Hypercalcemia is a condition caused due to high calcium level in the blood which leads to weak bones, kidney stones and also interferes in the functioning of heart and brain. Hypercalcemia treatment involves treatment of underlying diseases, restoring extracellular volume, correcting electrolyte deficiencies (potassium and magnesium), and reducing bone resorption.

Major Market Drivers and Restraints:

• Expanding label indications
• Increasing hip and knee replacement procedures will increase the risk of hypercalcemia
• Increasing surgical procedures
• Severe threat of damage to nervous system

Hypercalcemia Treatment Market Segmentation:

By technology the market for hypercalcemia treatment is segmented into bisphosphonates, calcitonin, glucocorticoids, denosumab, calcimimetics.

On the basis of distribution channel the market is segmented into direct and retail.

On the basis of end-users the hypercalcemia treatment market is segmented into hospitals and clinics.

On the basis of geography, hypercalcemia treatment market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Speak to Analyst about this Report Visit @ databridgemarketresearch.com/speak-to-analyst/?dbmr=globa...

Hypercalcemia Treatment Market Competitive Analysis:

The global hypercalcemia treatment market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of hypercalcemia treatment market for global, Europe, North America, Asia Pacific and South America.

Hypercalcemia Treatment Market Major Market Competitors:

Some of the major players operating in hypercalcemia treatment market are:

• AbbVie
• Amgen
• Merck
• Novartis and OPKO Health
• DiaSorin
• Rockwell Medical
• Kyowa Hakko Kirin
• Fujirebio
• Pharma AG
• Sun Pharmaceutical Industries Ltd.
• Mylan N.V.
• Pfizer Inc.
• Amgen Inc.
• Novartis AG
• Dr. Reddy’s Laboratories Ltd.
• Cipla Inc.
• Bayer Pharma AG
• Sun Pharmaceutical Industries Ltd. among others.

View Full Report Visit @ databridgemarketresearch.com/reports/global-hypercalcemia...

Related Report

Global In Situ Hybridization Market – Industry Trends and Forecast to 2024

Global In Situ Hybridization Market By Product (Fluorescent In Situ Hybridization, Chromogenic In Situ Hybridization), By Application (Cell Biology Research, Neuroscience, Oncology and Others), By End-User (Pharma And Biotechnology Laboratories, Research And Academics, Hospitals, Others), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Report Access: databridgemarketresearch.com/reports/global-in-situ-hybri...

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: databridgemarketresearch.com/blog/
Follow us on LinkedIn: www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.
News-ID: 808699 • Views: 113
More releasesMore releases

You can edit or delete your press release here: